Did you know... Ireland's life sciences sector exports more than 45 billion Euros annually and employs over 50,000 people? All but one of the world's 25 largest biotech and pharma companies have a presence in Ireland? Ireland is the world's third largest exporter of pharmaceuticals and has over 50 FDA approved pharma and biopharma plants?  What can Biocair and Aramex Ireland do to support you? They have a fully integrated service managed by the Aramex network with Biocair's expertise. Creation and assistance with shipment paperwork and labelling to ensure a swift and compliant…

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced that it will be showcasing its newly expanded ADME-Tox research capabilities at the 25th North American International Society for the Study of Xenobiotics (ISSX) Meeting, which will be held from September 10-13 in Boston, MA. “We’re excited to be back in Boston to meet with the research community attending ISSX,” said Dr. Christopher Black, BioIVT Senior Vice President ADME-Tox. “At last year’s meeting, we announced that XenoTech had joined BioIVT, significantly expanding…

- Positive feedback from pre-IND meeting with FDA confirms Hikma’s continued development of AT307 under the 505(b)(2) regulatory pathway - Abbreviated 505(b)(2) submission offers an efficient and streamlined development pathway with reduced risk Cambridge, UK, 7th September 2023: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, is pleased to announce further progress from Hikma in the development of ready-to-use ("RTU") injectable medicine AT307, following a recent positive pre-investigational new drug…

Read the September edition of eNews here, featuring: ► Welcome from Tony Jones, CEO ► What is the Importance of Training and Developing Your Workforce? ► Why is Working for a One Nucleus Member Company Good for You? ► Revitalising Conference Websites: Enhancing Engagement for Life Science Companies ► Are You Asking the Right Questions when Assessing Your Next Lab Space? ► New Horizons in Genetic Screening    

  One Nucleus and GTM Global Enter into Collaboration to Support Member International and Connectivity Cambridge and London, UK, 05 September 2023 One Nucleus, the leading Life Science membership group supporting the translation of bio-innovation into successful businesses and ultimately patient benefit is delighted to announce the collaborative partnership with GTM Global (GTM), the unique online interactive ecosystem that engages with ambitious tech and digital scale-up businesses to expand internationally. One Nucleus members will be able access GTM’s high-touch programme of…

Sign up to receive the latest regulatory updates from Boyds: https://boydconsultants.com/sign-up/ In this month's newsletter they shared recent guidance and key updates from the regulatory agencies: Food and Drug Association (FDA)​ European Medicines Agency (EMA) Medicines and Healthcare products Regulatory Agency (MHRA) European Commission (EC) World Health Organisation (WHO)   On 5 October, Boyds is hosting a free webinar on 'How to successfully operationalize real-world data collection alongside expanded access programs', for more info and how to sign up, click here.

More than half the Cambridge startups [60.7%] listed in Seedtable’s ‘Startups in Cambridge to Watch’ list last month [July 2023] have already appeared on cofinitive’s #21toWatch list in previous years. This timely revelation, as the nominations window for #21toWatch 2024 opens, confirms that the #21toWatch awards really do spotlight the brightest and best from across Cambridge and beyond. #21toWatch recognises the outstanding people, companies and innovations in our region, providing high-level exposure and increasing opportunities for funding and investment for the winning candidates. Every…

Check out and subscribe to the latest newsletter from Stevenage Bioscience Catalyst. Highlights include:  UBS Asset Management and Reef Group secure approval for one of Europe's largest Life Sciences campuses in Europe Cell and Gene Therapy, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapies Plasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogenic cell immunotherapies BioWednesday Stevenage: 6 September

In the latest edition of the Penningtons Manches Cooper LLP BioBrief newsletter, their team explores university-generated IP and in particular what it means for students who are involved and contributing to such IP... Read more.

Lab-on-chip technology for screening live tumor Glasgow, UK based – ScreenIn3D reports on how their proprietary lab-on-a-chip technology is enabling cancer researchers to miniaturize their testing of biopsy tissue samples across a wide range of modalities and to test both single and combination drug therapies on live tissue samples. Combining the latest advances in microfluidics and 3D cell culture – ScreenIn3D’s unique chip technology enables researchers to use as few as 1000 cells for tens of 3D cancer screening experiments. ScreenIn3D has recently secured investment…